Skip to content

Randomized controlled trial of functional magnetic stimulation of sacral nerve in the treatment of neurogenic bladder after spinal cord injury

Randomized controlled trial of functional magnetic stimulation of sacral nerve in the treatment of neurogenic bladder after spinal cord injury

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100045148
Enrollment
Unknown
Registered
2021-04-07
Start date
2021-06-01
Completion date
Unknown
Last updated
2021-11-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Spinal cord injury

Interventions

experimental group A:Functional magnetic stimulation of sacral nerve
experimental group B:Acupuncture
Control group:Acupuncture

Sponsors

The Affiliated Hospital of Southwest Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1.Definitely diagnosed as spinal cord injury with a course of more than one month; 2.Age: 18-60 years old; 3.Urodynamics clearly indicates detrusor and/or sphincter dysfunction; 4.Neurogenic bladder that requires intermittent cleaning to the urine.

Exclusion criteria

Exclusion criteria: 1.Patients with metal implants in the lumbosacral area; 2.Patients with abnormal autonomic nerve reflexes; 3.Patients with cognitive dysfunction who cannot cooperate; 4.Patients with unstable vital signs; 5.Patients with a history of bladder Botox injection or bladder/sphincter surgery Patients; 6.Patients with unstable fractures.

Design outcomes

Primary

MeasureTime frame
Bladder diary;Pelvic floor electromyography;Urodynamics;

Secondary

MeasureTime frame
International Basic Data Set of Spinal Cord Injury Quality of Life;

Countries

China

Contacts

Public ContactHuang Maomao

The Affiliated Hospital of Southwest Medical University

973342240@qq.com+86 18384308766

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 11, 2026